Crossref
SF3B1 splicing modulation to overcome platinum and PARP inhibitor resistance in ovarian cancer
European Journal of Cancer · 2026-11 · 248 · 117643
DOI: 10.1016/j.ejca.2026.117643 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von B. Shay und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shay, B., Evans, Z., Conway, C., Tothova, Z., & Stover, E. (2026). SF3B1 splicing modulation to overcome platinum and PARP inhibitor resistance in ovarian cancer. European Journal of Cancer, 248, 117643. https://doi.org/10.1016/j.ejca.2026.117643
Vancouver
Shay B, Evans Z, Conway C, Tothova Z, Stover E. SF3B1 splicing modulation to overcome platinum and PARP inhibitor resistance in ovarian cancer. European Journal of Cancer. 2026;248:117643. doi:10.1016/j.ejca.2026.117643
BibTeX
@article{Shay2026,
author = {Shay, B. and Evans, Z. and Conway, C. and Tothova, Z. and Stover, E.},
title = {SF3B1 splicing modulation to overcome platinum and PARP inhibitor resistance in ovarian cancer},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117643},
doi = {10.1016/j.ejca.2026.117643}
}
EUVIMED